Human haematopoietic stem cell lineage commitment is a continuous process

…, C Hirche, C Lutz, EC Buss, D Nowak, T Boch… - Nature cell …, 2017 - nature.com
Blood formation is believed to occur through stepwise progression of haematopoietic stem
cells (HSCs) following a tree-like hierarchy of oligo-, bi-and unipotent progenitors. However, …

[HTML][HTML] Single-cell proteo-genomic reference maps of the hematopoietic system enable the purification and massive profiling of precisely defined cell states

…, D Ordoñez-Rueda, B Ramasz, T Boch… - Nature …, 2021 - nature.com
Single-cell genomics technology has transformed our understanding of complex cellular
systems. However, excessive cost and a lack of strategies for the purification of newly identified …

Mutational hierarchies in myelodysplastic syndromes dynamically adapt and evolve upon therapy response and failure

…, I Palme, C Xanthopoulos, T Boch… - Blood, The Journal …, 2016 - ashpublications.org
Clonal evolution is believed to be a main driver for progression of various types of cancer
and implicated in facilitating resistance to drugs. However, the hierarchical organization of …

Diagnosis of invasive aspergillosis in hematological malignancy patients: performance of cytokines, Asp LFD, and Aspergillus PCR in same day blood and …

…, G Johnson, F Prüller, A Wölfler, T Niedrist, T Boch… - Journal of Infection, 2018 - Elsevier
Background Aspergillus spp. induce elevated levels of several cytokines. It remains
unknown whether these cytokines hold value for clinical routine and enhance diagnostic …

Galactomannan testing and Aspergillus PCR in same-day bronchoalveolar lavage and blood samples for diagnosis of invasive aspergillosis

…, M Reinwald, H Flick, D Buchheidt, T Boch - Medical …, 2017 - academic.oup.com
In recent years galactomannan antigen testing (GM) and also Aspergillus PCR have become
increasingly important for diagnosis of invasive aspergillosis (IA). Whether or not these …

Identification of leukemic and pre-leukemic stem cells by clonal tracking from single-cell transcriptomics

…, C Lutz, D Nowak, JC Jann, C Pabst, T Boch… - Nature …, 2021 - nature.com
Cancer stem cells drive disease progression and relapse in many types of cancer. Despite
this, a thorough characterization of these cells remains elusive and with it the ability to …

Performance of the Bronchoalveolar Lavage Fluid Aspergillus Galactomannan Lateral Flow Assay With Cube Reader for Diagnosis of Invasive Pulmonary …

…, J Frank, B Spiess, SR Mehta, T Boch… - Clinical Infectious …, 2021 - academic.oup.com
Background The Aspergillus Galactomannan Lateral Flow Assay (LFA) is a rapid test for the
diagnosis of invasive aspergillosis (IA) that has been almost exclusively evaluated in …

[PDF][PDF] Antigen presentation safeguards the integrity of the hematopoietic stem cell pool

…, C Hirche, C Andresen, C Robens, PS Werner, T Boch… - Cell Stem Cell, 2022 - cell.com
Hematopoietic stem and progenitor cells (HSPCs) are responsible for the production of blood
and immune cells. Throughout life, HSPCs acquire oncogenic aberrations that can cause …

Special FDA designations for drug development: orphan, fast track, accelerated approval, priority review, and breakthrough therapy

DT Michaeli, T Michaeli, S Albers, T Boch… - The European Journal of …, 2023 - Springer
Background Over the past decades, US Congress enabled the US Food and Drug Administration
(FDA) to facilitate and expedite drug development for serious conditions filling unmet …

[HTML][HTML] Targeting the EGF receptor family in non-small cell lung cancer—Increased complexity and future perspectives

T Boch, J Köhler, M Janning, S Loges - Cancer Biology & Medicine, 2022 - ncbi.nlm.nih.gov
Lung cancer remains the leading cause of cancer-associated mortality worldwide, but with
the emergence of oncogene targeted therapies, treatment options have tremendously …